Pfizer Inc. (PFE) Expands Research Commitment To Ophthalmology Through Licensing Agreement With Quark Biotech, Inc.; Atugen AG Will Receive Payments Up To US$95 Million
9/26/2006 12:06:22 PM
More...
|
ALTANA Pharma AG (AAA) And Atugen AG Renew Target Validation And License Agreement
10/19/2005 5:12:45 PM
More...
|
Xantos Biomedicine AG And Atugen AG Collaborate To Validate Cancer Target
10/19/2005 5:12:43 PM
More...
|
Atugen AG And ASINEX Ltd. Announce Discovery Program For Novel Protein Kinase Target
10/19/2005 5:12:38 PM
More...
|
Professor Cy Stein Joins Atugen AG Scientific Advisory Board
10/19/2005 5:12:32 PM
More...
|
Atugen Raises EUR5M As Fuel For SiRNA Drug Development
10/19/2005 5:10:35 PM
More...
|
Atugen AG Raises $6.1 Million In Third Round
10/19/2005 5:10:33 PM
More...
|